Author

Yasuaki Anami

Brown Foundation Institute of Molecular Medicine for the Prevention of Human DiseasesORCID 0000-0001-5136-7708Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Ali AzhdariniaiD· 1 shared Cara Guernsey-BiddleiD· 1 shared Ha Tran· 1 shared Joan JacobiD· 1 shared Julie Haewon RoweiD· 1 shared Kendra S. CarmoniD· 1 shared Kyoji TsuchikamaiD· 1 shared Peyton C. HighiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ali AzhdariniaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Antibody-Drug Conjugates Targeting the EGFR Ligand Epiregulin Elicit Robust Anti-Tumor Activity in Colorectal Cancer

Joan Jacob, Yasuaki Anami, Peyton C. High, Zhengdong Liang, Shraddha Subramanian, Sukhen C. Ghosh, Solmaz AghaAmiri, Cara Guernsey-Biddle, Ha Tran, Julie Haewon Rowe, Ali Azhdarinia, Kyoji Tsuchikama, Kendra S. Carmon

This study develops and tests EREG-targeting ADCs showing efficacy in both RAS mutant and wildtype CRC, with high potency and safety in preclinical models.

Cancer Research · Dec 18, 2024Peer-reviewedCancer Biology